Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

A generous gift of £3.3million from the entrepreneur, private investor and philanthropist Mr André Hoffmann has secured the future of an Oxford Chair in Developmental Medicine.

Professor Georg Holländer, an expert in developmental biology and Head of the Department of Paediatrics at Oxford, currently holds the Chair. With this support, Professor Holländer will be able to advance our knowledge of how cells of the immune system grow and differentiate during foetal development and early life, resulting in the normal formation of our tissues and organs. This knowledge is vital in underpinning regenerative medicine, an area of scientific study that promises to transform patient care in the 21st century by reactivating cells to restore function after injury or disease.

Read the full story 

Similar stories

Promising discovery for treatment of neuromuscular diseases

Research led by Carlo Rinaldi and Catheryn Lim discovered that a naturally-occurring isoform of an androgen receptor can be used in therapy for spinal and bulbar muscular atrophy, and shows potential for other diseases.

University of Oxford researchers among recipients of Ireland and UK joint research awards for digital humanities in €6.5m boost for interdisciplinary research partnerships

Dr Samantha Vanderslott (Oxford Vaccine Group) and Dr Claas Kirchhelle (University College Dublin) have had their three-year project ‘Typhoid, Cockles, and Terrorism’ about the history of typhoid in Dublin successfully funded.

The Oxford-Harrington Rare Disease Centre initiates first disease priority area: Friedreich’s Ataxia

The Oxford-Harrington Rare Disease Centre is redoubling efforts to develop a therapeutics programme for Friedreich’s Ataxia.

Why we must expand newborn screening

Early diagnosis is of primary importance both to obtain the best effect of innovative medications and to accelerate their development, writes Professor Laurent Servais.

Celebrating Early Careers Researchers on International Women's Day

In these short interviews, Anna Kordala and Jane Millar talk about the research they do at the Department of Paediatrics.

Coronavirus vaccination linked to substantial reduction in hospitalisation, real-world data suggests

The first study to describe the effects in real-world communities of the Oxford coronavirus vaccine has been reported in a pre-print publication today, showing a clear reduction in the risk of hospitalisation from COVID-19 amongst those who have received the vaccine.